Table 4.
Details of colon seeding medium composition and preparation
Component | Stock concentration | Volume added | Final concentration | Recommended storage condition |
---|---|---|---|---|
| ||||
WRN-conditioned media | 100× | 6.5 ml | 65× | −20 °C freezer |
Base media* | 100× | 3.2 ml* | 32× | 4 °C fridge |
B27 | 50× | 200 μl | 1× | −20 °C freezer |
N2 | 100× | 100 μl | 1× | −20 °C freezer |
N-acetyl cysteine | 500 mM | 10 μl | 500 μM | −20 °C freezer |
A83-01 | 500 μM | 10 μl | 500 nM | −20 °C freezer |
Thiazovivin** | 6.25 mM | 4 μl | 2.5 μM | −80 °C freezer |
SB202190 | 30 mM | 3.33 μl | 10 μM | −20 °C freezer |
EGF | 250 μg/ml | 2 μl | 50 ng/ml | −20 °C freezer |
human [Leu15]-Gastrin | 100 μM | 1 μl | 10 nM | −20 °C freezer |
Prostaglandin E2 | 10 mM | 2 μl*** | 5 nM | −80 °C freezer |
Final volume | 10.03 ml |
Base media consists of Advanced DMEM/F12, 2mM Glutamax, 10 mM HEPES, 100 units/ml penicillin/streptomycin as described in Table 1.
Nicotinamide is removed and thiazovivin is used instead of Y-27632 dihydrochloride in seeding medium to allow differentiation into secretory cell types in monolayers as reported by Kozuka et al.27
Prostaglandin E2 should be diluted before use. Make a dilution of 1 μl PGE stock to 349 pl base media. Add 2 μl PGE dilution for 10 ml media